Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sinco Pharmaceuticals Holdings Ltd. ( (HK:6833) ) has provided an announcement.
Sinco Pharmaceuticals Holdings Limited has announced a board meeting scheduled for August 27, 2025, to review and approve the interim results for the first half of the year ending June 30, 2025. The meeting will also consider the recommendation for an interim dividend payment, which could impact shareholder returns and reflect the company’s financial health.
More about Sinco Pharmaceuticals Holdings Ltd.
Sinco Pharmaceuticals Holdings Limited is a company incorporated under the laws of the Cayman Islands with limited liability. It operates within the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products.
Average Trading Volume: 211,740
Technical Sentiment Signal: Hold
Current Market Cap: HK$426.9M
For detailed information about 6833 stock, go to TipRanks’ Stock Analysis page.